Novartis AG
(NYSE:NVS)
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
top performing NVS trades
Daniel Goldman
House (D-NY)
11.20%
Sheldon Whitehouse
Senate (D-RI)
6.80%
Thomas R. Carper
Senate (D-DE)
6.20%
Donald Beyer
House (D-VA)
-2.30%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Novartis trades made by congress members.
Sheldon WhitehouseSenate (D-RI) | $1K - $15K | stock | Sale (Partial) | May 20, 2024 | Apr 09, 2024 | Senate |
Sheldon WhitehouseSenate (D-RI) | $15K - $50K | stock | Purchase | Oct 17, 2023 | Sep 20, 2023 | Senate |
Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Sale | Aug 13, 2023 | Jul 10, 2023 | House |
Thomas R. CarperSenate (D-DE) | $1K - $15K | stock | Purchase | May 01, 2023 | Apr 26, 2023 | Senate |
Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Purchase | Apr 17, 2023 | Mar 31, 2023 | House |
Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Sale (Partial) | Mar 20, 2023 | Feb 27, 2023 | House |
 Kevin HernHouse (R-OK) | $1K - $15K | stock | Sale | Feb 14, 2023 | Jan 31, 2023 | House |
 John RutherfordHouse (R-FL) | $1K - $15K | stock | Sale | Apr 19, 2022 | Mar 16, 2022 | House |
Donald BeyerHouse (D-VA) | $1K - $15K | stock | Sale | Mar 03, 2022 | Feb 28, 2022 | House |
Donald BeyerHouse (D-VA) | $1K - $15K | stock | Purchase | Feb 01, 2022 | Jan 27, 2022 | House |
Donald BeyerHouse (D-VA) | $1K - $15K | stock | Sale | Jan 01, 2022 | Dec 22, 2021 | House |
 Shelley Moore CapitoSenate (R-WV) | $1K - $15K | stock | Sale | Jan 21, 2022 | Dec 15, 2021 | Senate |